Tithi Biswas

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Stereotactic radiosurgery for glioblastoma: retrospective analysis
    Tithi Biswas
    Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Radiat Oncol 4:11. 2009
  2. doi request reprint Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma
    Tithi Biswas
    Department of Radiation Oncology, East Carolina University, Greenville, North Carolina, USA
    Radiother Oncol 103:367-72. 2012
  3. ncbi request reprint Low-dose radiosurgery for benign intracranial lesions
    Tithi Biswas
    Department of Radiation Oncology, University of Rochester Medical Center Rochester, New York 14642 8647, USA
    Am J Clin Oncol 26:325-31. 2003
  4. doi request reprint Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques
    Matthew T Studenski
    Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Med Dosim 38:48-54. 2013
  5. doi request reprint Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
    Tithi Biswas
    Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York 14642, USA
    Int J Radiat Oncol Biol Phys 77:79-85. 2010

Detail Information

Publications5

  1. pmc Stereotactic radiosurgery for glioblastoma: retrospective analysis
    Tithi Biswas
    Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Radiat Oncol 4:11. 2009
    ..This retrospective study was done to better understand the conditions for which stereotactic radiosurgery (SRS) for glioblastoma may be efficacious...
  2. doi request reprint Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma
    Tithi Biswas
    Department of Radiation Oncology, East Carolina University, Greenville, North Carolina, USA
    Radiother Oncol 103:367-72. 2012
    ..We sought to evaluate involved field radiation therapy (IFRT) following ASCT and patterns of recurrence, overall survival (OS), and disease specific survival (DSS)...
  3. ncbi request reprint Low-dose radiosurgery for benign intracranial lesions
    Tithi Biswas
    Department of Radiation Oncology, University of Rochester Medical Center Rochester, New York 14642 8647, USA
    Am J Clin Oncol 26:325-31. 2003
    ..If lower, more homogeneous radiation doses produce responses as durable as higher doses, then toxicity might be further reduced...
  4. doi request reprint Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques
    Matthew T Studenski
    Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Med Dosim 38:48-54. 2013
    ..Although inefficient, the IMRT technique is the most clinically feasible because of the increased mean OAR dose with the VMAT technique. Quality assurance of the beams, especially the junction regions, is essential...
  5. doi request reprint Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
    Tithi Biswas
    Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York 14642, USA
    Int J Radiat Oncol Biol Phys 77:79-85. 2010
    ..We evaluated the role of involved field radiation therapy (IFRT) post-ASCT for patients initially induced with cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP) or, more recently, rituximab-CHOP (R-CHOP)...